This inventor holds 1 USPTO granted patent. Top assignee: Beijing University of Technology. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Gail Petuna Risbridger: Innovator in Prostate Cancer Diagnosis
Introduction
Gail Petuna Risbridger is a prominent inventor based in East Malvern, Australia. She has made significant contributions to the field of medical diagnostics, particularly in the area of prostate cancer. Her innovative work has the potential to improve the early detection and treatment of this prevalent disease.
Latest Patents
Gail Petuna Risbridger holds a patent for a method of diagnosing abnormal cell growth. This invention relates specifically to diagnosing mammals with abnormal prostatic cell growth or those predisposed to developing such conditions. The method involves screening for the modulation of the expression of follistatin protein or its derivatives. More specifically, it aims to diagnose prostate cancer by screening for the co-expression of different forms of follistatin protein. This groundbreaking approach could lead to more effective diagnostic techniques in the medical field.
Career Highlights
Throughout her career, Gail has been dedicated to advancing medical research and diagnostics. Her work at the Beijing University of Technology has allowed her to collaborate with other experts in the field, further enhancing her contributions to medical science.
Collaborations
Gail Petuna Risbridger has worked alongside David Morritz De Kretser, a fellow researcher, to explore innovative solutions in the realm of cancer diagnostics. Their collaboration has fostered a productive environment for research and development.
Conclusion
Gail Petuna Risbridger's innovative work in diagnosing prostate cancer represents a significant advancement in medical diagnostics. Her contributions have the potential to change the landscape of cancer detection and treatment, ultimately benefiting countless individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
